Status:
COMPLETED
A Prospective Surveillance Trial to Evaluate the Safety of Optison in Clinical Practice.
Lead Sponsor:
GE Healthcare
Conditions:
Echocardiography
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This prospective surveillance trial will gather safety information for Optison when it is used in routine practice.
Eligibility Criteria
Inclusion
- The subject is over 18 years old.
- The subject has been scheduled for an Optison-enhanced echocardiography exam.
- The subject has provided signed and dated informed consent.
Exclusion
- Known hypersensitivity to perflutren, blood, blood products or albumin.
Key Trial Info
Start Date :
May 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
1039 Patients enrolled
Trial Details
Trial ID
NCT00730964
Start Date
May 1 2008
End Date
October 1 2009
Last Update
June 12 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GE Healthcare
Princeton, New Jersey, United States, 08540